Omeros reported $2.05 in EPS Earnings Per Share for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acelrx Pharmaceuticals ACRX:US USD -0.94 0.26
Adma Biologics ADMA:US USD -0.06 0.02
Alnylam Pharmaceuticals ALNY:US USD -1.68 1.01
Biomarin Pharmaceutical BMRN:US USD 0.36 0.4
Cytokinetics CYTK:US USD -1.45 0.07
Dynavax Technologies DVAX:US USD 0.45 0.02
Gilead Sciences GILD:US USD 1.67 0.23
Heron Therapeutics HRTX:US USD -0.17 0.21
Insmed INSM:US USD -1.21 0.12
Intercept Pharmaceuticals ICPT:US USD -0.5 8.3
Knight Therapeutics Inc GUD:CN CAD -0.13 0.14
Macrogenics MGNX:US USD 0.21 0.61
Mirati Therapeutics MRTX:US USD -3.51 0.42
Omeros OMER:US USD 2.05 2.33
Pacira Pharmaceuticals PCRX:US USD 0.8 0.16
Pfizer PFE:US USD 1.14 0.64
Regulus Therapeutics RGLS:US USD -0.4 0.1
Rockwell Medical RMTI:US USD -0.4 0.16
Sangamo Biosciences SGMO:US USD -0.32 0.02
Sarepta Therapeutics SRPT:US USD -1.24 1.7
United Therapeutics UTHR:US USD 2.67 2.24
Vertex Pharmaceuticals VRTX:US USD 3.76 0.25
Vital Therapies VTL:US USD -1.62 0.93
Xoma XOMA:US USD -0.63 0.15